RE:RE:The first three.The screening process takes approximately 2 weeks, so the first patient treated should occur late this year or early next year. I look forward to demonstrating to the medical community what the Theralase PDC anti-cancer technology is capable of .
Read more at https://www.stockhouse.com/news/press-releases/2016/12/09/theralase-commences-phase-ib-clinical-study#3HHo30Ss82bSeIeI.99
TLT started Ph1b NMIBC trial on the 9th of december 2016 . I understand trial and error but there could be a lack of focus . Come on 2 week screening process . I'm convinced that TLD-1433 is safe and tolerable at low and high dose . The doctors involved are probably also , time to reach the finish line on this Ph1b . I go hunting one rabbit at a time ....TLT should focus on getting approval for Ph 2 .
GO TLT GO
GO AM GO
GO JV GO
HAPPY WEDNESDAY